-
-
-
Skurtveit, Svetlana Ondrasova & Clausen, Thomas
(2023).
Hun kjemper mot abstinensene smertene og skammen har norge en opioid krise.
A-magasinet : uketillegg til Aftenposten.
ISSN 0807-5654.
s. 16–28.
-
Skurtveit, Svetlana Ondrasova
(2023).
Dobbeltdiagnose hos LAR pasienter: En populasjonsbasert registerbasert studie fra Tsjekkia og Norge.
-
Husberg-Bru, Vendela; Bergland, Anne Katrine; Skurtveit, Svetlana Ondrasova & Lid, Torgeir Gilje
(2023).
Pasientforløp etter en Alkohol-intervensjon på Somatisk Sykehus: TRAITS Hospital .
-
Skurtveit, Svetlana Ondrasova
(2023).
POINT project: Hvordan unngå en opioidepidemi i Norge: Fokus på behandling av kroniske smerter.
-
Borchgrevink, Petter Chr.; Glette, Mari; Jost, Peter Dietrich; Woodhouse, Astrid; Landmark, Tormod & Bjertnæs, J
[Vis alle 9 forfattere av denne artikkelen]
(2023).
General practitioners`response to a coping-oriented treatment concept as an alternative to opioid prescriptions for chronic pain (NOMED).
-
vambheim, Sara Magelssen; Hjellvik, Vidar; Odsbu, Ingvild; Skurtveit, Svetlana Ondrasova; Ekholdt, Christopher & Granan, Lars-Petter Ness
[Vis alle 8 forfattere av denne artikkelen]
(2023).
Postoperative Opioid Use in Norway - Patterns of Prolonged Use.
-
Skurtveit, Svetlana Ondrasova; Hamina, Aleksi & Odsbu, Ingvild
(2023).
Overdose risk-increasing medication is more often dispensed to individuals dying of overdoses related to pharmaceutical available opioids compared to individuals dying of overdoses related to other substances: a population-based register study.
-
Odsbu, Ingvild; Hjellvik, Vidar; Hamina, Aleksi & Skurtveit, Svetlana Ondrasova
(2023).
Prevalence of pain-related and mental health diagnoses among persistent opioid users: a population-based registry-linkage study.
-
Høibø, Trond; Skurtveit, Svetlana Ondrasova & Lid, Torgeir Gilje
(2023).
RGP Involvement in Initiation of Opioids for Chronic Non-Cancer Pain associated with Opioid Dose and Concurrent Drug Use? A Web-Based Survey.
-
Skurtveit, Svetlana Ondrasova
(2023).
Langvarig bruk av forskrevne opioider til smertebehandling.
-
Nestvold, Håkon Høydal; Skurtveit, Svetlana Ondrasova; Hamina, Aleksi; Hjellvik, Vidar & Odsbu, Ingvild
(2023).
Socioeconomic risk factors for long-term opioid use: a national registry-linkage study.
-
Skurtveit, Svetlana Ondrasova
(2023).
Medikamentrelaterte overdoser – hva viser tallene?
-
-
Skurtveit, Svetlana Ondrasova
(2023).
Medikamentrelaterte overdoser – hva viser tallene? Mennesker med langvarige smertetilstander.
-
Gjesdal, Kine; Høibø, Trond & Skurtveit, Svetlana Ondrasova
(2023).
Hvordan unngå en opioidepidemi i Norge: Fokus på behandling av kroniske smerter.
-
Skurtveit, Svetlana Ondrasova; Nestvold, Håkon Høydal & Odsbu, Ingvild
(2023).
Flere bruker opioider over lang tid.
Glimt.
ISSN 1890-8489.
s. 10–11.
-
-
Skurtveit, Svetlana Ondrasova
(2023).
POINT prosjektet.
-
Skurtveit, Svetlana Ondrasova
(2023).
Overdoser av reseptbelagte opioider.
-
-
Skurtveit, Svetlana Ondrasova
(2023).
Flere kvinner dør av smertestillende piller.
-
-
Skurtveit, Svetlana Ondrasova
(2022).
Hvordan unngå en opioid epidemi i Norge: Fokus på behandling av kroniske smerter.
-
Skurtveit, Svetlana Ondrasova
(2022).
Smertemedisin ulovlig markedsført: – Jeg mistet sju år av mitt liv.
[Internett].
NRK.
-
Hamina, Aleksi; Odsbu, Ingvild; Borchgrevink, Petter Chr.; Chen, Li-Chia; Clausen, Thomas & Espnes, Ketil Arne
[Vis alle 18 forfattere av denne artikkelen]
(2022).
Cohort Description: Preventing an Opioid Epidemic in Norway – Focusing on Treatment of Chronic Pain (POINT) – A National Registry-Based Study.
Clinical Epidemiology.
ISSN 1179-1349.
14,
s. 1477–1486.
doi:
10.2147/CLEP.S382136.
-
Hamina, Aleksi; Odsbu, Ingvild; Clausen, Thomas & Skurtveit, Svetlana Ondrasova
(2022).
Intentional overdoses and associated mental health challenges, an overlooked sub-population of overdoses.
-
Skurtveit, Svetlana Ondrasova
(2022).
Individuals dying of overdoses related to pharmaceutical opioids differ from individuals dying of overdoses related to other substances.
-
Skurtveit, Svetlana Ondrasova
(2022).
Overdoser og forskrevne opioider.
-
Skurtveit, Svetlana Ondrasova
(2022).
LAR pasienter med smerte og smertebehandling i LAR.
-
-
-
-
-
-
-
-
Skurtveit, Svetlana Ondrasova
(2022).
Opioide dødsfall og forskrivning av opioider.
-
Skurtveit, Svetlana Ondrasova
(2022).
Medikamentbruk og overdoser.
-
Skurtveit, Svetlana Ondrasova & Odsbu, Ingvild
(2022).
Resultater fra tildelingsbrev og utvalgte resultater fra pågående forskningsprosjekt (POINT).
-
Skurtveit, Svetlana Ondrasova & Odsbu, Ingvild
(2022).
Resultater fra oppdrag i tildelingsbrevet for 2020 – fokus på blåreseptordningen.
-
Skurtveit, Svetlana Ondrasova
(2022).
KoRus.
[Internett].
https://korusoslo.no/2022/08/29/hvordan-unnga-en-opioide-epi.
-
Skurtveit, Svetlana Ondrasova
(2022).
Bruk av forskrevne opioider og dødelige overdoser: Velkommen til Norsk Sykepleierforbund of NSFs faggruppe for sykepleiere innen psykisk helse og rus sin markering av Overdosedagen 2022.
-
Skurtveit, Svetlana Ondrasova
(2022).
Bruk av forskrevne opioider. To dagers Nasjonalt overdosenettverk-nettverksamling.
-
-
-
-
-
Bukten, Anne; Lokdam, Nicoline; Skjærvø, Ingeborg; Ugelvik, Thomas; Skurtveit, Svetlana Ondrasova & Gabrhelík, Roman
[Vis alle 20 forfattere av denne artikkelen]
(2022).
PriSUD-Nordic—Diagnosing and Treating Substance Use Disorders in the Prison Population: Protocol for a Mixed Methods Study.
JMIR Research Protocols.
ISSN 1929-0748.
11(3).
doi:
10.2196/35182.
Fulltekst i vitenarkiv
Vis sammendrag
Background:
A large proportion of the prison population experiences substance use disorders (SUDs), which are associated with poor physical and mental health, social marginalization, and economic disadvantage. Despite the global situation characterized by the incarceration of large numbers of people with SUD and the health problems associated with SUD, people in prison are underrepresented in public health research.
Objective:
The overall objective of the PriSUD (Diagnosing and Treating Substance Use Disorders in Prison)-Nordic project is to develop new knowledge that will contribute to better mental and physical health, improved quality of life, and better life expectancies among people with SUD in prison.
Methods:
PriSUD-Nordic is based on a multidisciplinary mixed method approach, including the methodological perspectives of both quantitative and qualitative methods. The qualitative part includes ethnographic fieldwork and semistructured interviews. The quantitative part is a registry-based cohort study including national registry data from Norway, Denmark, and Sweden. The national prison cohorts will comprise approximately 500,000 individuals and include all people imprisoned in Norway, Sweden, and Demark during the period from 2000 to 2019. The project will investigate the prison population during three different time periods: before imprisonment, during imprisonment, and after release.
Results:
PriSUD-Nordic was funded by The Research Council of Norway in December 2019, and funding started in 2020. Data collection is ongoing and will be completed in the first quarter of 2022. Data will be analyzed in spring 2022 and the results will be disseminated in 2022-2023. The PriSUD-Nordic project has formal ethical approval related to all work packages.
Conclusions:
PriSUD-Nordic will be the first research project to investigate the epidemiology and the lived experiences of people with SUD in the Nordic prison population. Successful research in this field will have the potential to identify significant areas of benefit and will have important implications for ongoing policy related to interventions for SUD in the prison population.
-
Skurtveit, Svetlana Ondrasova
(2022).
Forskrevne opioider og overdoser.
-
Skurtveit, Svetlana Ondrasova
(2022).
OxyContin: Ser vi amerikanske trender i Norge?
-
Odsbu, Ingvild; Handal, Marte; Borchgrevink, Petter Chr.; Clausen, Thomas & Skurtveit, Svetlana Ondrasova
(2022).
Endringer i opioidbruken i Norge må tas på dypeste alvor.
Tidsskrift for Den norske legeforening.
ISSN 0029-2001.
doi:
10.4045/tidsskr.21.0909.
Fulltekst i vitenarkiv
-
-
Skurtveit, Svetlana Ondrasova
(2022).
Hvordan unngå en opioid epidemi i Norge: Fokus på behandling av kroniske smerter .
-
Stenehjem, Jo S.; Røise, Olav; Nordseth, Trond; Clausen, Thomas; Natvig, Bård & Skurtveit, Svetlana Ondrasova
[Vis alle 12 forfattere av denne artikkelen]
(2021).
Injury Prevention and long-term Outcomes following Trauma - the IPOT project: a protocol for prospective nationwide registry-based studies in Norway.
-
Rosseland, Leiv Arne; Stenehjem, Jo S.; Nordseth, Trond; Clausen, Thomas; Natvig, Bård & Skurtveit, Svetlana Ondrasova
[Vis alle 12 forfattere av denne artikkelen]
(2021).
The Injury Prevention and Outcomes following Trauma project: a prospective nationwide registry-based study in Norway.
-
Odsbu, Ingvild; Handal, Marte; Hjellvik, Vidar & Skurtveit, Svetlana Ondrasova
(2021).
Trends in long-term use of prescribed opioids in Norway 2010-2019.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
30,
s. 53–53.
doi:
10.1002/pds.5305.
Vis sammendrag
Background
Since 2008, patients with chronic, non-malignant pain conditions can get reimbursement for analgesic opioids. There is limited evidence of analgesic effect of opioids when used over a long time period while the risk of adverse effects is increasing. Thus, closely monitoring of opioid consumption at the population level to detect signs of escalation is needed.
Objectives
To investigate whether there has been a change in the number of long-term users of prescribed opioids over time and according to reimbursement scheme (reimbursed opioids for palliative care, reimbursed opioids for chronic, non-malignant pain, or non-reimbursable opioids).
Methods
Data were retrieved from the Norwegian Prescription Database. The study population consisted of all individuals filling at least one prescription of an opioid (ATC N02A) during 2010-2019. Long-term use was defined as being dispensed more than 180 defined daily doses or more than 4500 mg oral morphine equivalents of opioids a given year and filling prescriptions in at least 3 quarters of the year. Individuals were divided into mutually exclusive groups according to reimbursement scheme in a hierarchical manner; reimbursed opioids for palliative care > reimbursed opioids for chronic, non-malignant pain > non-reimbursable opioids. The proportion of long-term opioid users according to reimbursement scheme was calculated.
Results
The number of long-term opioid users increased from 49,993 in 2010 to 59,996 in 2019. The increase over time was almost solely attributed to an increase among chronic, non-malignant pain patients. The number of long-term users receiving non-reimbursable opioids and opioids for palliative care remained stable over time. In 2019, the majority of the 59,996 long-term users received non-reimbursable opioids only (n=38,006), followed by long-term users receiving opioids for chronic, non-malignant pain (n=14,812), and long-term users receiving palliative care (n=7,178).
Conclusions
The number of long-term opioid users have increased by 20% (10,000 individuals) over an 11 years period in Norway due to an increase in number of long-term users receiving reimbursed opioids to treat chronic, non-malignant pain. More studies are needed to understand whether the introduction of the reimbursement scheme for chronic pain patients has been a contributing factor to the observed increase in number of long-term opioid users and why the majority of the long-term opioid users do not receive opioids according to the reimbursement scheme for chronic, non-malignant pain.
-
Odsbu, Ingvild; Handal, Marte; Hjellvik, Vidar & Skurtveit, Svetlana Ondrasova
(2021).
Trends in long-term use of prescribed opioids in Norway 2010-2019.
-
Odsbu, Ingvild; Handal, Marte; Hjellvik, Vidar & Skurtveit, Svetlana Ondrasova
(2021).
Trends in long-term use of prescribed opioids in Norway 2010-2019. .
-
Skurtveit, Svetlana Ondrasova
(2021).
Hvordan unngå en opioidepidemi i Norge: Fokus på behandlin av langvarige smerter.
Glimt.
ISSN 1890-8489.
-
Skurtveit, Svetlana Ondrasova
(2021).
Hvordan unngå en opioid epidemi i Norge: Fokus på behandling av langvarige smerter .
Glimt.
ISSN 1890-8489.
2(1),
s. 26–27.
-
Heger, Katrine; Skipsfjord, Julia; Kiselev, Yury; Burns, Margrete Larsen; Aaberg, Kari Modalsli & Johannessen, Svein Ivar
[Vis alle 8 forfattere av denne artikkelen]
(2021).
Changes in the use of antiseizure medications with focus on children and adolescents in Norway 2009-18.
-
Skipsfjord, Julia; Heger, Katrine; Skurtveit, Svetlana; Aaberg, Kari Modalsli; Kiselev, Yury & Burns, Margrete Larsen
[Vis alle 8 forfattere av denne artikkelen]
(2021).
Forbruk av antiepileptika hos barn og unge i Skandinavia-er det likt?
-
-
Handal, Marte; Skurtveit, Svetlana; Odsbu, Ingvild; Kieler, Helle; Nørgaard, Mette & Öztürk, Buket
[Vis alle 12 forfattere av denne artikkelen]
(2019).
In utero opioid exposure and risk of ADHD in childhood: A Scandinavian registry study.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
28(S2).
doi:
10.1002/pds.4864.
-
Skurtveit, Svetlana; Kiselev, Yury; Handal, Marte; Stoltenberg, Camilla; Reichborn-Kjennerud, Ted & Suren, Pål
[Vis alle 8 forfattere av denne artikkelen]
(2019).
Co-Occurring Neuropsychiatric Diagnoses and Use of Psychotropic Drugs in Children with Autism Spectrum Disorder.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
doi:
10.10002/pds.4864.
-
Wood, Mollie; Mahic, Milada; Handal, Marte; Skurtveit, Svetlana; Lund, Ingunn Olea & Hernandez-Diaz, Sonia
(2019).
Risk of Neonatal Abstinence Syndrome Following Prenatal Exposure to Methadone vs Buprenorphine.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
doi:
10.1002/pds.4864.
-
Lund, Ingunn Olea; Skurtveit, Svetlana; Handal, Marte; Bukten, Anne; Torvik, Fartein Ask & Ystrøm, Eivind
[Vis alle 7 forfattere av denne artikkelen]
(2019).
Association of Constellations of Parental Risk With Children's Subsequent Anxiety and Depression: Findings From a HUNT Survey and Health Registry Study.
-
Burdzovic, Jasmina; Torvik, Fartein Ask; Ystrøm, Eivind; Skurtveit, Svetlana; Handal, Marte & Lund, Ingunn Olea
(2019).
Alcohol use disorder (AUD) in offspring following exposure to parental risk constellations during adolescence: A combined HUNT survey and health registries study.
-
Steingrímsdóttir, Ólöf Anna; Nielsen, Christopher Sivert; Odsbu, Ingvild; Skurtveit, Svetlana Ondrasova & Handal, Marte
(2018).
Langvarig smerte i Norge.
I Grøholt, Else Karin; Bøhler, Linn & Hånes, Hanna (Red.),
Folkehelserapporten - Helsetilstanden i Norge.
Folkehelseinstituttet.
-
Handal, Marte; Nechanska, Blanka; Skurtveit, Svetlana; Mahic, Milada; Mravcik, Viktor & Gabrhelik, Roman
(2018).
Hospitalization of children after prenatal exposure to methadone and buprenorphine: National registry studies from Czech Republic.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
-
Lupattelli, Angela; Chambers, Christina; Bandoli, Gretchen; Handal, Marte; Skurtveit, Svetlana & Nordeng, Hedvig Marie Egeland
(2018).
Maternal use of benzodiazepines and z‐hypnotics during pregnancy and developmental outcomes in offspring at 5 years of age.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
27(S2),
s. 173–173.
doi:
10.1002/pds.4629.
-
Skurtveit, Svetlana; Bramness, Jørgen Gustav; Hjellvik, Vidar; Hartz, Ingeborg; Nesvåg, Ragnar & Hauge, Lars Johan
[Vis alle 7 forfattere av denne artikkelen]
(2018).
Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
-
Mahic, Milada; Hernandez-Diaz, Sonia; Wood, Mollie; Odsbu, Ingvild; Nørgaard, Mette & Kieler, Helle
[Vis alle 8 forfattere av denne artikkelen]
(2018).
Infections in children after prenatal exposure to methadone and buprenorphine: Nordic registry study.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
-
Hoff, Mari; Schei, Berit; Skovlund, Eva; Skurtveit, Svetlana; Langhammer, Arnulf & Syversen, Unni
[Vis alle 10 forfattere av denne artikkelen]
(2018).
Gir bruk av protonpumpehemmere økt risiko for brudd? Data fra HUNT 3. .
-
Muller, Ashley Elizabeth; Odsbu, Ingvild; Sjøgren, Per; Clausen, Thomas & Skurtveit, Svetlana
(2018).
Prescribed opioid analgesic use developments in the Scandinavian countries, 2006-2017.
-
Handal, Marte; Skurtveit, Svetlana; Nechanská, Blanka; Mahic, Milada; Mravčík, Viktor & Gabrhelík, Roman
(2018).
Hospitalization of children after prenatal exposure to methadone and buprenorphine: National registry study from the Czech Republic.
-
Nechanská, Blanka; Mahic, Milada; Mravčík, Viktor; Gabrhelík, Roman; Skurtveit, Svetlana & Handal, Marte
(2018).
Sykelighet hos barn som har vært eksponert for LAR legemidler i fosterlivet. En registerstudie fra Tsjekkia.
-
Handal, Marte; Nechanská, Blanka; Skurtveit, Svetlana; Mahic, Milada; Mravčík, Viktor & Gabrhelík, Roman
(2018).
Hospitalization of Children after Prenatal Exposure to Methadone and Buprenorphine: National Registry Studies from the Czech Republic.
-
Lund, Ingunn Olea; Skurtveit, Svetlana; Handal, Marte; Bukten, Anne; Torvik, Fartein Ask & Ystrøm, Eivind
[Vis alle 7 forfattere av denne artikkelen]
(2018).
Parental drinking and child long-term depression and anxiety: A longitudinal combined survey and registry study.
-
Handal, Marte; Nechanská, Blanka; Mravčík, Viktor; Skurtveit, Svetlana; Lund, Ingunn Olea & Gabrhelík, Roman
[Vis alle 7 forfattere av denne artikkelen]
(2017).
Neonatal Outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
-
Nechanska, Blanka; Mravcik, Viktor; Skurtveit, Svetlana; Lund, Ingunn Olea; Gabrhelik, Roman & Engeland, Anders
[Vis alle 7 forfattere av denne artikkelen]
(2017).
Condition of newborns of women received OMT and opiates during pregnancy: comparison of Czech and Norwegian cohorts.
-
Handal, Marte; Nechanska, Blanka; Lund, Ingunn Olea; Gabrhelik, Roman; Mahic, Milada & Engeland, Anders
[Vis alle 8 forfattere av denne artikkelen]
(2017).
OMT or drug abuse during pregnancy - does it affect the offspring? Results from Nationwide registry studies in the Czech Republic and Norway.
-
Holdø, Ingvild; Bramness, Jørgen Gustav; Handal, Marte; Hansen, Berit Marina Hjelde; Hjellvik, Vidar & Skurtveit, Svetlana
(2017).
Infants With dispensed hypnotics have a greater risk of developing hyperkinetic disorder in School age.
-
Holdø, Ingvild; Bramness, Jørgen Gustav; Skurtveit, Svetlana; Handal, Marte; Hansen, Berit Hjelde & Hjellvik, Vidar
(2017).
Infants with Sleep Problems have a Greater Risk of Developing ADHD in school age.
-
Muller, Ashley; Clausen, Thomas & Skurtveit, Svetlana
(2017).
Building an abstinent network to support quality of life gains through treatment.
Vis sammendrag
Research questions - How does QoL change as patients progress through treatment? - Can certain social network developments support QoL improvements?
-
Handal, Marte; Mahic, Milada; Hjellvik, Vidar; Lund, Ingunn Olea; Øhman, Inger & Wikner, Birgitta Norstedt
[Vis alle 13 forfattere av denne artikkelen]
(2016).
Background and design: A Scandinavian cohort of pregnant women in opioid maintenance treatment during pregnancy: long term consequences for the child (ScopeOMT).
-
Hartz, Ingeborg; Skurtveit, Svetlana; Hjellvik, Vidar; Furu, Kari; Nesvåg, Ragnar & Handal, Marte
(2016).
Antidepressant Drug use Among Adolescents in Norway from 2004 to 2013‐ A Population‐Based Register Study.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
-
Nesvåg, Ragnar; Hartz, Ingeborg; Bramness, Jørgen Gustav; Hjellvik, Vidar; Handal, Marte & Skurtveit, Svetlana
(2016).
Differences Between Genders in Antipsychotic Medication Among Children and Adolescents – Patterns in Use and Underlying Mental Disorders.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
-
Skovlund, Eva; Handal, Marte; Selmer, Randi Marie; Brandlistuen, Ragnhild Eek & Skurtveit, Svetlana
(2016).
Language Development in 3 Year Old Children After Prenatal Exposure to Opioids.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
-
Handal, Marte; Mahic, Milada; Hjellvik, Vidar; Lund, Ingunn Olea; Øhman, Inger & Wikner, Birgitta Nordstedt
[Vis alle 13 forfattere av denne artikkelen]
(2016).
Background and design: A Scandinavian cohort of
pregnant women
in opioid maintenance
treatment
during pregnancy: long term consequences for the child
(ScopeOMT).
-
Hoff, Mari; Skurtveit, Svetlana; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne & Syversen, Unni
[Vis alle 8 forfattere av denne artikkelen]
(2015).
Use of anti-osteoporotic drugs among women in central Norway after a forearm fracture.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
25,
s. 96–96.
-
Hartz, Ingeborg; Skurtveit, Svetlana; Hjellvik, Vidar; Furu, Kari; Nesvåg, Ragnar & Handal, Marte
(2015).
Antidepressant drug use among adolescents during 2004-2013
– a population-based linkage study between the Nationwide prescription database and patient register
.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
25,
s. 95–95.
-
-
Hartz, Ingeborg; Skurtveit, Svetlana; Steffenak, Anne Kjersti Myhrene; Karlstad, Øystein & Handal, Marte
(2015).
Psychotropic drug use among 0-17 year olds during 2004-2013: a nationwide prescription database study.
-
Lund, Ingunn Olea; Skurtveit, Svetlana & Handal, Marte
(2015).
Commentary on Raitasalo et al. (2015): The great potential in nation-wide registers to study prescription drug use and abuse.
Addiction.
ISSN 0965-2140.
110(4),
s. 644–645.
doi:
10.1111/add.12856.
-
Nielsen, Christopher Sivert; Handal, Marte; Skurtveit, Svetlana & Steingrímsdóttir, Ólöf Anna
(2014).
Langvarige smertetilstander.
I Stoltenberg, Camilla; Grøholt, Else Karin; Hånes, Hanna & Reneflot, Anne (Red.),
Folkehelserapporten 2014. Helsetilstanden i Norge.
Folkehelseinstituttet.
ISSN 978-82-8082-636-7.
s. 141–147.
-
Hartz, Ingeborg; Handal, Marte; Tverdal, Aage & Skurtveit, Svetlana
(2014).
Pediatric off-label use of melatonin - a register-linkage study between the Norwegian Prescription Database and Patient Registry.
-
Hartz, Ingeborg; Skurtveit, Svetlana; Steffenak, Anne Kjersti Myhrene; Karlstad, Øystein & Handal, Marte
(2014).
Psychotropic drug use among 0-17 year olds during 2004-2013: a Nationwide prescription database study.
-
Hartz, Ingeborg; Skurtveit, Svetlana; Steffenak, Anne Kjersti Myhrene; Karlstad, Øystein & Handal, Marte
(2014).
Psychotropic drug use among 0-17 year olds during 2004-2013: a Nationwide prescription database study.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
24,
s. 57–57.
-
Hartz, Ingeborg; Skurtveit, Svetlana & Handal, Marte
(2014).
Trends in melatonin use during 2004 to 2011 among children and adolecents. A Nationwide prescription database study.
-
Hartz, Ingeborg; Skurtveit, Svetlana; Karlstad, Øystein; Steffenak, Anne Kjersti Myhrene & Handal, Marte
(2014).
Psychotropic drug use among 0-17 year olds during 2004-2013: a nationwide prescription database study.
-
Furu, Kari; Karlstad, Øystein; Skurtveit, Svetlana & Selmer, Randi
(2012).
Treatment of ADHD with Psychostimulants in Patients on Opioid Maintenance Therapy (OMT) in Norway – A Nationwide Study.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
21,
s. 424–424.
-
Skurtveit, Svetlana; Log, Tomas & Handal, Marte
(2012).
Røyking kan øke risikoen for gjentatt bruk av smertestillende legemidler som inneholder opioider.
BestPractice Norge.
s. 18–22.
-
Steffenak, Anne Kjersti Myhrene; Nordström, Gun; Larsson, Bodil Wilde; Skurtveit, Svetlana & Hartz, Ingeborg
(2012).
Increase in psychotropic drug use between 2006 to 2010 among adolescents in Norway- a nationwide prescription database study.
-
Steffenak, Anne Kjersti Myhrene; Nordström, Gun; Larsson, Bodil Wilde; Skurtveit, Svetlana & Hartz, Ingeborg
(2012).
Increase in Psychotropic Drug Use between 2006 and 2010 among Adolescents in Norway: A Nationwide Prescription Database Study.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
21,
s. 153–153.
-
Skurtveit, Svetlana; Selmer, Randi; Tverdal, Aage; Nystad, Wenche; Furu, Kari & Handal, Marte
(2012).
Use of Prescription Databases in Studies of SSRI Exposure in Pregnancy. Impact of Misclassification on Measured Risk Associations.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
21,
s. 374–375.
-
Lund, Ingunn Olea; Engeland, Anders; Furu, Kari; Ravndal, Edle; Skurtveit, Svetlana & Handal, Marte
(2012).
Prescription Drug Use among Pregnant Women in Opioid Maintenance Treatment.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
21,
s. 388–388.
-
Mauseth, Siri Ann; Spigset, Olav & Skurtveit, Svetlana
(2012).
Patterns of Use of Antimuscarinic Drugs for Overactive Bladder: A Study of the Norwegian Prescription Database.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
21,
s. 66–67.
-
Holdo, Ingvild; Handal, Marte; Skurtveit, Svetlana & Bramness, Jørgen Gustav
(2012).
Parent's Use of Hypnotics Predicts Alimemazine Use in Infants and Toddlers.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
21,
s. 142–143.
-
Neutel, CI; Skurtveit, Svetlana & Berg, Christian Lie
(2012).
Dramatic Increases in the Use of Strong Opioids in the Elderly.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
21,
s. 172–173.
-
Lund, Ingunn Olea; Handal, Marte; Engeland, Anders; Furu, Kari; Ravndal, Edle & Skurtveit, Svetlana
(2011).
USE OF PRESCRIBED DRUGS FOR THE NERVOUS SYSTEM AMONG WOMEN IN OPIOID MAINTENANCE TREATMENT BEFORE AND DURING PREGNANCY IN NORWAY, 2004-2008.
Drug and Alcohol Review.
ISSN 0959-5236.
30,
s. 57–57.
-
Steffenak, Anne Kjersti Myhrene; Nordström, Gun; Larsson, Bodil Wilde; Skurtveit, Svetlana; Furu, Kari & Hartz, Ingeborg
(2011).
Mental Distress and Subsequent Use of Psychotropic Drugs Among Adolescents - A Prospective Register Linkage Study.
Vis sammendrag
Norsk
Indonesisik
-
Hartz, Ingeborg; Log, Tomas; Selmer, Randi Marie; Furu, Kari; Tverdal, Aage & Skille, Eivind Åsrum
[Vis alle 7 forfattere av denne artikkelen]
(2011).
Does patterns of maternal use of potentially addictive drugs reproduce in their children ?
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
21,
s. 23–23.
-
Hartz, Ingeborg; Log, Tomas; Selmer, Randi Marie; Furu, Kari; Tverdal, Aage & Skille, Eivind Åsrum
[Vis alle 7 forfattere av denne artikkelen]
(2011).
Does patterns of maternal use of potentially addictive drugs reproduce in their children ?
-
Hjellvik, Vidar; Handal, Marte; Skurtveit, Svetlana & Hartz, Ingeborg
(2011).
The relationship between unfavourable lifestyle in the ages 13-25 and subsequent use of potentially addictive prescription drugs in Norwegian men and women.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
21,
s. 25–25.
-
Hjellvik, Vidar; Handal, Marte; Skurtveit, Svetlana & Hartz, Ingeborg
(2011).
The relationship between unfavourable lifestyle in the ages 13-25 and subsequent use of potentially addictive prescription drugs in Norwegian men and women.
-
Hartz, Ingeborg; Skurtveit, Svetlana; Selmer, Randi Marie; Tverdal, Aage & Skille, Eivind Åsrum
(2011).
Ingeborg Hartz, Høyskolen i Hedemark, Elverum Reproducibility of patterns use of potentially addictive drugs over generations – a recordlinkage study.
-
Hartz, Ingeborg; Bramness, Jørgen Gustav & Skurtveit, Svetlana
(2011).
Prescription of antidepressants to patients on opioid maintenance therapy.
-
Neutel, C; Berg, Christian Lie & Skurtveit, Svetlana
(2011).
Multiple Prescribers or Doctor Shopping? Opioid Use in Elderly Norwegians.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
20,
s. S105–S105.
-
Neutel, C; Berg, Christian Lie & Skurtveit, Svetlana
(2011).
Quantifying Usage of Potentially Addictive Medication in the Elderly.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
20,
s. S105–S105.
-
Hjellvik, Vidar; Handal, Marte; Skurtveit, Svetlana & Hartz, Ingeborg
(2011).
The Relationship between Unfavourable Behaviour in the Ages 13-25 and Subsequent Use of Potentially Addictive Prescription Drugs in Norwegian Men and Women.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
20,
s. S110–S111.
-
Skurtveit, Svetlana; Furu, Kari; Handal, Marte; Borchgrevin, Petter & Fredheim, Olav Magnus
(2011).
To Which Extent Does a Cohort of New Users of Weak Opioids Develop Persistent or Probable Problematic Opioid Use?
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
20,
s. S223–S223.
-
Steffenak, Anne Kjersti Myhrene; Skurtveit, Svetlana; Furu, Kari; Larsson, Bodil Wilde; Nordström, Gun & Hartz, Ingeborg
(2011).
Mental Distress and Subsequent Use of Psychotropic Drugs among Adolescents - A Prospective Register Linkage Study.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
20,
s. S262–S262.
-
Hartz, Ingeborg; Selmer, Randi Marie; Tverdal, Aage; Skille, Eivind Åsrum & Skurtveit, Svetlana
(2011).
Does Patterns of Maternal Use of Potentially Addictive Drugs Reproduce in Their Children?
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
20,
s. S265–S265.
-
Hartz, Ingeborg; Myhrene, Anne K; Furu, Kari & Skurtveit, Svetlana
(2011).
Dietary Habits and Subsequent Use of Psychotropic Drug Use in Adolescents - A Register Linkage Study.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
20,
s. S168–S168.
-
Handal, Marte; Skurtveit, Svetlana; Furu, Kari; Rønning, Marit & Engeland, Anders
(2011).
Use of Legally Prescribed Opioid Analgesics in Pregnant Women and Risk of Spontaneous Preterm Birth. A Population Based Cohort Study, Norway 2004-2008.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
20,
s. S75–S75.
-
Gjersing, Linn Renathe; Jonassen, Kristine Vinge; Skurtveit, Svetlana; Bramness, Jørgen Gustav & Clausen, Thomas
(2011).
A descriptive registry study of those who died from drug-induced deaths between 2006-2008 in Oslo.
-
Bukten, Anne; Røislien, Jo; Skurtveit, Svetlana & Clausen, Thomas
(2011).
GENDER DIFFERENCES IN CRIME DURING PERIODS OF TRANSITION IN OPIOID MAINTENANCE TREATMENT: A NATIONAL COHORT STUDY.
Drug and Alcohol Review.
ISSN 0959-5236.
30,
s. 16–16.
-
Hartz, Ingeborg; Steffenak, Anne Kjersti Myhrene; Furu, Kari & Skurtveit, Svetlana
(2011).
Dietary Habits and Subsequent Use of Psychotropic Drug Use in Adolescents - A Register Linkage Study.
-
Furu, Kari; Skurtveit, Svetlana; Strøm, Hanne & Rønning, Marit
(2010).
Reseptregisteret 2004-2009 : - en kilde til informasjon.
Norsk Farmaceutisk Tidsskrift.
ISSN 0029-1935.
118(12),
s. 29–31.
-
Hartz, Ingeborg & Skurtveit, Svetlana
(2010).
Increase in use of hypnotic drugs among children and adolescents aged 0-17 years- a nationwide prescription database study.
Pharmacoepidemiology and Drug Safety.
ISSN 1053-8569.
Vis sammendrag
Background: Nationwide information on patterns of use of hypnotic drug in the pediatric/adolescent population over time, is scarce. Objectives: To study trends (2004-2008) and level of long-term use of hypnotic drugs in 0-17 year olds according to age, gender and hypnotic drug subcategories Methods: Prescription data on hypnotic drugs and reimbursable comedication were drawn from the nationwide Norwegian Prescription Database. Period (1-year) prevalence use was estimated for the period 2004-2008. Proportion of continued users throughout the period was calculated. Results: Hypnotic drug use in 0-17 year olds increased in the period, from 8,9 to 10,8 per 1000 inhabitants, attributed a more than doubling in use of melatonin. Use of antihistamines declined by 20 per cent in the period. In both gender, overall use of hypnotic drugs peaked among 1-2 year olds. Thereafter, hypnotic drug use (antihistamines) decreased threefold. During 6 to 12 years of age use of melatonin increased steadily, most pronounced in boys. During 13-17 years of age, the level of hypnotic drug use stabilized in boys, but a threefold increase in use was observed among girls. At 17 years of age 23 per 1000 of all girls and 15 per 1000 of all boys retrieved a prescription on a hypnotic drug. 60% of all male and 48% of all female users in 2005 retrieved prescriptions on reimbursable comedication for chronic diseases. Level of long-term use were higher in this sub-group, 31% of the boys and 23 % of the girls. Conclusions: There is a trend of increasing hypnotic drug use in children and adolescents in Norway, attributed increasing use of melatonin. Use of systemic antihistamines is declining, but still constitute the hypnotic drug of choice among 1-2 year old children. A threefold increase in hypnotic drug use among girls from 14 to 17 years of age warrants further attention.
-
Fredheim, Olav Magnus; Borchgrevink, Petter Chr.; Nordstrand, Berit; Clausen, Thomas & Skurtveit, Svetlana
(2010).
Prescription of analgesics to patients in opioid maintenance therapy - a pharmacoepidemiological study.
-
Nordbø, Arve; Skurtveit, Svetlana; Borchgrevink, Petter Chr.; Kaasa, Stein & Fredheim, Olav Magnus
(2010).
Is transdermal buprenorphine for chronic non-malignant pain used long term without co-medication with other potentially addictive drugs?
-
Skurtveit, Svetlana; Furu, Kari; Handal, Marte; Borchgrevink, Petter Chr. & Fredheim, Olav Magnus
(2010).
To which extent does incident and persistent use of weak opioids predict problematic opioid use?
-
Svendsen, Kristian; Borchgrevink, Petter Chr.; Fredheim, Olav Magnus & Skurtveit, Svetlana
(2010).
How are opioids used in Norway? Persistent use, utilization of depot formulation and age profile in non-palliation patients.
-
Fredheim, Olav Magnus; Skurtveit, Svetlana; Breivik, Harald; Svendsen, Kristian; Kaasa, Stein & Borchgrevink, Petter Chr.
(2010).
Cancer patients acount for only 3% of patients receiving opioids in Norway.
Palliative Medicine.
ISSN 0269-2163.
24(4).
-
Fredheim, Olav Magnus; Skurtveit, Svetlana; Breivik, Harald; Svendsen, Kristian; Kaasa, Stein & Borchgrevink, Petter Chr.
(2010).
A revision of EAPC and WHO three step analgesic ladder may be needed.
Palliative Medicine.
ISSN 0269-2163.
24(4).
-
Svendsen, Kristian; Fredheim, Olav Magnus; Romundstad, Pål Richard; Borchgrevink, Petter Chr. & Skurtveit, Svetlana
(2010).
Defining persistent opioid use from prescription registries.
-
Svendsen, Kristian; Moroz, Anna; Fredheim, Olav Magnus; Skurtveit, Svetlana & Borchgrevink, Petter Chr.
(2010).
Longitudinal study of new non-cancer users of prescribed strong opioids.
-
-
Skjærvø, Ingeborg; Bukten, Anne; Skurtveit, Svetlana & Clausen, Thomas
(2018).
Substance use and crime - Characteristics of victim and offender roles in a longitudinal study of patients entering substance use treatment.
Universitetet i Oslo.
ISSN 978-82-8377-250-0.
-
Muller, Ashley Elizabeth; Skurtveit, Svetlana & Clausen, Thomas
(2017).
Quality of life, substance use disorders, and social lives: Exploring one-year outcomes and intrinsic links.
Universitetet i Oslo.
ISSN 978-82-8377-139-8.
Fulltekst i vitenarkiv
Vis sammendrag
Substance use disorders are increasingly being recognized as chronic diseases, with important treatment implications: not only should a finite course of treatment not be expected to be curative, but outcomes of interest must be relevant to the patient and not limited to reduced substance use. While quality of life is a standard outcome measure among other chronic disease treatment, the substance use disorder treatment field has lagged behind in systematically evaluating it. Sustained contact with the treatment system lasting beyond intensive inpatient treatment appears best to maintain treatment’s benefits long-term, therefore the social environments of patients – the larger contexts of their lives, including but not limited to treatment – must also be addressed.
The overall objective of this thesis was to examine changes in quality of life along with natural treatment progression and explore the relationship of these changes to underresearched social factors in order to inform the clinical approach to patients’ social lives. The specific aims were to identify patterns in poor quality of life at entry to SUD treatment; to examine how quality of life changes along with social network developments through the treatment course; and to validate and confirm the utility of a new quality of life instrument.
This thesis used data from The Norwegian Cohort of Patients in Opioid Maintenance Treatment and Other Drug Treatment study, an observational, prospective study of adults entering substance use disorder treatment in 21 facilities
throughout Norway. 548 patients entering treatment enrolled at were administered a battery of questionnaires, such as the EuropASI, HSCL-25, and QOL10, through structured interviewed by trained facility staff. One year later, regardless of treatment progression or drop out, participants answered the same questionnaires through interviews with research staff. 338 were included in the longitudinal analysis.
The majority of the sample entered treatment with extremely impaired quality of life as measured through a single item, along with substance-using social networks, poor mental health, and polysubstance use. Depression was associated with the poorest quality of life among women, while physical inactivity, weight dissatisfaction, and eating alone were the most important factors for men. Opioid maintenance treatment medication was a protective factor for both genders. After one year, 75% of participants were still receiving treatment, 9% had completed, and 15% amount as at study inclusion reported no network (17.5%). Global and social quality of life measured by the QOL10 improved for the entire sample, although global quality of life remained below population norms. The trend in each of the three treatment status groups, and statistically significant for those still in treatment, was for participants who gained or maintained an abstinent network to report the largest gains in quality of life, and for participants who gained a substance-using network or were socially isolated to report the smallest, or clinically negligible, improvements. In a validation study of the QOL10, factor analysis revealed the QOL10 to measure two domains described as “global quality of life” and “social quality of life”. The global domain correlated negatively with symptoms of clinical anxiety, depression, and physical inactivity; the social domain was only weakly correlated to anxiety. Both domains had satisfactory internal validity, scores were easily calculated, and the QOL10 as a whole presented minimal administrative and participant burden.
At both treatment initiation and one year later, we found quality of life to correlate with lesser explored factors such as physical inactivity and social isolation. These vulnerabilities, along with mental health, should be evaluated immediately in the clinical setting and addressed through exercise and network in
-
Tjagvad, Christian; Clausen, Thomas & Skurtveit, Svetlana
(2016).
Addictive medication in relation to drug treatment and overdose death.
Universitetet i Oslo.
ISSN 978-82-8333-308-4.
Fulltekst i vitenarkiv
Vis sammendrag
Background
The involvement of the addictive medications, benzodiazepines (BZDs) and prescription opioids, including
opioid maintenance treatment (OMT) medications, have increasingly contributed to the high overdose
death rates in Denmark and Norway during the past decades. Investigating prescription patterns and
patient behavior in relation to drug treatment and overdose deaths is important to increase our knowledge
on how these addictive medications are used, misused, and how they may contribute to overdose deaths.
Study aims
The overall aim of the thesis was to acquire new knowledge of the involvement of addictive medications in
the treatment of populations with drug use disorders (DUDs) and also in overdose deaths to improve
treatment approaches and reduce detrimental outcomes in a vulnerable group of individuals. More
specifically the aim was to investigate prescription patterns and use of addictive medication in relation to
drug treatment and overdose deaths among populations in Denmark and Norway. Furthermore, to
compare overdose cases with and without detection of legally prescribed addictive medications and
investigate factors associated with having detection of non-prescribed addictive medication.
Materials and methods
This thesis was based on three different cohorts/samples from two countries: A Danish nationwide cohort
including individuals admitted for treatment for DUDs in 2000-2010 (n=33,203); a Norwegian sample
including overdose deaths in the capital city, Oslo, in 2006-2008 (n=167), and; a Danish sample including
overdose deaths in Copenhagen, Aarhus, and Odense Municipality in 2008-2011 (n=130). The
cohorts/samples were linked with data from population registries, local based registries, and journal
reviews by using a unique identification number assigned to all Danish and Norwegian citizens.
Results
Overall, in the period after entering treatment and in the period prior to overdose death, addictive
medication was often prescribed to individuals with DUD. In both periods, inappropriate prescription
patterns were identified. During the first year after admission to DUD treatment, about one-quarter of the
individuals (26.2%) were prescribed BZDs. Of these, about one-third (35.5%) were prescribed BZDs at dose
levels that might indicate inappropriate use, and about one-third (34.6%) were prescribed more than one
type of BZDs. Particularly individuals with opioid use (43.2%) were commonly prescribed BZDs. Admitting to
treatment for a DUD did not increase the specialized psychiatric treatment coverage of this patient group,
disregarding use of prescribed BZDs. Among overdose deaths in Denmark and Norway, the prescribed
doses of the addictive medications among the deceased were in general higher than recommended.
Further, the control/monitoring measures were insufficient and allowing use of multiple prescribing
physicians (Norway), low levels of supervised intake of OMT medication (Denmark), and use of multiple
prescribed addictive medications (Denmark).
We investigated the deceased with detection of prescribed vs. non-prescribed addictive medication. In the
Norwegian sample, we found that a lower proportion of the deceased (with detection of the target
medications) had been prescribed BZDs (28.1%), strong analgesics (33.3%), or BZDs plus strong analgesics
(50.0%) four weeks prior to death. However, in Denmark the majority of deceased with methadone-related
overdose deaths (63.1%) were prescribed methadone as part of OMT at the time of death.
In the Norwegian sample, detection of non-prescribed BZDs and/or strong analgesics was associated with
younger age (a-OR=4.9; 95% CI, 1.4-18.0) and to have a permanent place of residence outside Oslo (a-
OR=2.9; 1.1-8.1). In the Danish sample, detection of non-prescribed methadone was associated with
younger age of 30 years or below (a-OR=9.5; 1.8-50.5), concomitant detection of 6-MAM/heroin (a-OR=3.1;
1.2-7.8), and non-prescribe
-
-
Skurtveit, Svetlana Ondrasova; Sakshaug, Solveig; Hjellvik, Vidar; Berg, Christian Lie & Handal, Marte
(2014).
Bruk av vanedannende legemidler i Norge 2005 - 2013. Basert på data fra Reseptregisteret.
Folkehelseinstituttet.
ISSN 978-82-8082-630-5.
Fulltekst i vitenarkiv
-
Bukten, Anne; Clausen, Thomas & Skurtveit, Svetlana
(2012).
Criminal convictions among patients in opioid maintenance treatment in Norway. A national cohort study.
Unipub forlag.
ISSN 978-82-8264-465-5.
-
Gustavsen, Ingebjørg Gussgard; Mørland, Jørg; Bramness, Jørgen Gustav & Skurtveit, Svetlana
(2012).
Zopiclone and traffic safety: introducing legalized blood zopiclone concentration limits - is it evidence based?
Universitetet i Oslo.
ISSN 9788282644075.
-
-
Hausken, Anne Margrethe; Skurtveit, Svetlana & Furu, Kari
(2011).
Epidemiology of anxiolytic and hypnotic drug use in the general population in Norway.
Unipub forlag.
ISSN 978-82-8264-056-5.
-
Rønning, Marit; Berg, Christian Lie; Furu, Kari; Litleskare, Irene; Sakshaug, Solveig & Selmer, Randi Marie
[Vis alle 8 forfattere av denne artikkelen]
(2010).
Reseptregisteret 2005–2009. Tema: Vanedannende legemidler / The Norwegian Prescription Database 2005–2009. Topic: Addictive drugs.
Nasjonalt folkehelseinstitutt.
ISSN 978-82-8082-408-0.
Fulltekst i vitenarkiv